Pfizer, Inc. vs Sarepta Therapeutics, Inc. — Stock Comparison

PFE
Pfizer, Inc.
$26.33
▼ 1.39%
vs
SRPT
Sarepta Therapeutics, Inc.
$21.49
▲ 2.92%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 4.4/10

Q·Score Breakdown

6.5
Neutral
Overall
4.4
Bearish
7.4
Quality
1.3
7
Health
6.9
5.6
Growth
3.3
6.7
Valuation
6.7
5.2
Sentiment
4.7
PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

SRPT

Healthy balance sheet and financial position.

currently unprofitable (-32% margin).

Analyst Consensus

HOLD
Target $29.00 (+10.2%)
27 analysts
HOLD
Target $21.78 (+1.4%)
23 analysts

Fundamentals

PFE
SRPT
19.4×
Trailing P/E
9.4×
Forward P/E
7.2×
12.4%
Profit Margin
-32.5%
75.8%
Gross Margin
-7.4%
8.9%
ROE
-53.5%
-1.2%
Revenue Growth
-32.7%
Earnings Growth
0.39
Beta
0.28
Price / Book
$149.8B
Market Cap
$2.3B
$22 – $29
52-Week Range
$10 – $65

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →